SE Women on Medicare Rarely Have Genetic Testing After Dx

Moderators

Southeastern Women on Medicare Rarely Have Genetic Testing After Being Diagnosed With Breast or Ovarian Cancer
August 21, 2018
Only 8% of women in the Southeastern United States on Medicare diagnosed with breast or ovarian cancer who met the criteria for BRCA1 and BRCA2 mutation testing had that testing done, according to a study. Read more...